Search Insights
articles
5 November
As part of the UK Government's emergency legislation measures to tackle the coronavirus pandemic, a significant change was made to Statutory Sick Pay (SSP), effective from 13 March 2020. If... Read Morearticles
3 November
Insolvency and Business Support expert Paul Caldicott looks at the impact of COVID-19 on Individual Voluntary Agreements (IVA's). This article was first published by the Institute Of Revenues Rating &... Read Moreevents
Many businesses have had to adapt in response to the challenges of the COVID-19 pandemic and as part of our Investing in Success series, Blake Morgan is delighted to have... Read More
events
Blake Morgan hosted our first FD Connect webinar on Thursday, 19 November. FD Connect is a dedicated forum powered by Blake Morgan exclusively for finance directors, CFO’s and other senior... Read More
articles
3 November
Potentially, the Corporate Insolvency and Governance Act 2020 (CIGA) is a piece of legislation that could wreak significant harm on the construction industry supply chain. Read Morearticles
3 November
Having summarised the changes introduced by the Corporate Insolvency and Governance Act 2020 (CIGA), we now look at how these affect contractual rights to terminate under construction and engineering contracts. Read Morearticles
3 November
The Corporate Insolvency and Governance Act 2020 (CIGA) came into effect on 26 June 2020, introducing significant changes to contracts for the supply of goods and services, including the majority,... Read Morearticles
30 October
The countdown is on for major changes to the way certain foods are labelled within the UK are introduced. On 1 October 2021, new allergen labelling laws in relation to... Read Morecase studies
27 October
The Judicial Committee of the Privy Council (JCPC) recently handed down an expedited judgment in Chu v Lau [2020] UKPC 24. The case was on appeal from the British Virgin... Read Morearticles
23 October
The Government anticipates that the Medicines and Healthcare Products Regulatory Agency ("MHRA") will make use of its powers under reg.174 of the Human Medicines Regulations 2012 ("HMRs"), and temporarily authorise... Read More